CT, MRI and PET imaging in peritoneal malignancy

Chirag M Patel, Anju Sahdev, Rodney H Reznek, Chirag M Patel, Anju Sahdev, Rodney H Reznek

Abstract

Imaging plays a vital role in the evaluation of patients with suspected or proven peritoneal malignancy. Nevertheless, despite significant advances in imaging technology and protocols, assessment of peritoneal pathology remains challenging. The combination of complex peritoneal anatomy, an extensive surface area that may host tumour deposits and the considerable overlap of imaging appearances of various peritoneal diseases often makes interpretation difficult. Contrast-enhanced multidetector computed tomography (MDCT) remains the most versatile tool in the imaging of peritoneal malignancy. However, conventional and emerging magnetic resonance imaging (MRI) and positron emission tomography (PET)/CT techniques offer significant advantages over MDCT in detection and surveillance. This article reviews established and new techniques in CT, MRI and PET imaging in both primary and secondary peritoneal malignancies and provides an overview of peritoneal anatomy, function and modes of disease dissemination with illustration of common sites and imaging features of peritoneal malignancy.

Figures

Figure 1
Figure 1
Normal mesothelium histological features. (a) Haematoxylin and eosin and (b) calretinin stains show normal mesothelium (arrows).
Figure 2
Figure 2
Subphrenic peritoneal deposit. Contrast-enhanced MDCT demonstrating a right subphrenic deposit (arrows) in (a) axial and (b) coronal planes from metastatic ovarian carcinoma.
Figure 3
Figure 3
Flow of peritoneal fluid. (a) Coronal and (b) sagittal pictorial diagram showing flow of peritoneal fluid (blue arrows) in relation to peritoneal spaces, ligaments, omenta and mesenteries. A, perihepatic and subdiaphragmatic flow; B, flow over the greater omentum; C, flow along the paracolic gutters; D, peritoneal fluid lying within the most dependent peritoneal space (pouch of Douglas); E, flow around gut serosa; F, communication with lesser sac. (Adapted from Amin Z, Reznek RH. Peritoneal metastases. In: Husband JE, Reznek RH, editors. Imaging in oncology. 3rd ed. Informa Healthcare; 2009. p. 1094–114; with permission.)
Figure 4
Figure 4
Subphrenic peritoneal disease. (a) Postgadolinium T1-weighted coronal MRI demonstrates nodular enhancement of bilateral subphrenic peritoneal deposits (arrows). (b) Coronal T2-weighted MRI of the upper abdomen shows a solitary right subphrenic deposit (arrows).
Figure 5
Figure 5
Peritoneal lymphoma. FDG PET/CT demonstrates diffuse deposits within the greater omentum (arrows) on (a) unenhanced CT. (b) Axial fused PET/CT and (c) coronal PET images show multiple areas of increased uptake within these and other greater omental deposits, including several retroperitoneal nodes (arrows).
Figure 6
Figure 6
Metastatic ovarian carcinoma with calcified peritoneal deposits on FDG PET/CT. (a) Contrast-enhanced MDCT shows multiple calcified (dashed arrows) and non-calcified (solid arrows) peritoneal deposits. (b) Coronal fused PET/CT demonstrating avid FDG uptake within the calcified and non-calcified deposits.
Figure 7
Figure 7
Metastatic pancreatic neuroendocrine tumour. Axial contrast-enhanced MDCT shows the typical hypervascular peritoneal deposits from a neuroendocrine tumour (arrows).
Figure 8
Figure 8
Pseudomyxoma peritonei. Axial contrast-enhanced CT shows the typical excessive scalloping of the liver and spleen from intraperitoneal mucin.
Figure 9
Figure 9
Subphrenic peritoneal deposit. Contrast-enhanced (a) axial and (b) coronal reformat MDCT showing a focal low attenuation peritoneal deposit (arrowed) from ovarian carcinomatosis.
Figure 10
Figure 10
Ovarian peritoneal carcinomatosis. Contrast-enhanced MDCT showing multiple peritoneal deposits involving the falciform ligament (black arrow) and gastrohepatic ligament (dashed arrows). Note the scalloping capsular splenic deposits (arrow heads) and nodular involvement of the greater omentum (solid white arrows).
Figure 11
Figure 11
Carcinoid tumour. Contrast-enhanced MDCT shows a spiculated soft tissue mass within the small bowel mesentery (arrow). The central calcification and soft tissue projections extending from the mass are typical of the associated desmoplastic reaction.
Figure 12
Figure 12
Greater omentum deposit. Axial contrast-enhanced CT shows extensive tumour involvement of the greater omentum (arrows), giving rise to an omental cake secondary to ovarian carcinoma. Note associated ascites and nodularity of the right paracolic peritoneal reflection (arrow heads).
Figure 13
Figure 13
Serosal deposits. (a) Axial contrast-enhanced MDCT shows small bowel serosal deposits from metastatic ovarian carcinoma (arrows). Note involvement of the greater omentum and extensive ascites. In a different case, (b) coronal T2-weighted MRI demonstrates multisegment small bowel serosal deposits (arrows).
Figure 14
Figure 14
Pelvic peritoneal involvement. (a) Sagittal T2-weighted MRI depicting peritoneal thickening and nodularity (arrows). Sagittal T1-weighted fat-saturated MRI (b) before and (c) after intravenous injection of gadolinium demonstrating marked abnormal peritoneal enhancement. Ascitic fluid (F) outlines the pelvic peritoneal spaces.
Figure 15
Figure 15
Malignant peritoneal mesothelioma. (a) Contrast-enhanced axial CT of the upper abdomen showing homogeneous tumour occupying the right subphrenic space (arrows), displacing adjacent liver parenchyma. (b) Axial images of the lower abdomen and (c) pelvis show an extensive confluent peritoneal mass (arrows) with associated ascites.
Figure 16
Figure 16
Desmoplastic small round cell tumour. MRI pelvis (a) sagittal T2-weighted and (b) axial T1-weighted images demonstrating a large lobulated peritoneal mass extending into the pelvis (arrows), which shows (c) enhancement after intravenous gadolinium injection (arrows).
Figure 17
Figure 17
Primary peritoneal lymphoma. Axial contrast-enhanced MDCT images show (a) diffuse confluent mass involving the small bowel mesentery, bowel serosa and greater omentum. (b) and (c) show extensive disease involving the root of the small bowel mesentery and bowel wall. Note associated ascites.

References

    1. Meyers MA. Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid. Am J Roentgenol Radium Ther Nucl Med. 1973;119:198–206.
    1. Standring S. Gray's anatomy: the anatomical basis of clinical practice. 39th ed. Churchill Livingstone; 2004. Peritoneum and peritoneal cavity.
    1. Coakley FV, Hricak H. Imaging of peritoneal and mesenteric disease: key concepts for the clinical radiologist. Clin Radiol. 1999;54:563–74. doi: 10.1016/S0009-9260(99)90018-1.
    1. DeMeo JH, Fulcher AS, Austin RF., Jr Anatomic CT demonstration of the peritoneal spaces, ligaments, and mesenteries: normal and pathologic processes. Radiographics. 1995;15:755–70.
    1. Gore RM, Levine LS. Textbook of gastrointestinal radiology. 3rd ed. Saunders; 2007. Peritoneal and retroperitoneal anatomy; pp. 2071–97.
    1. Meyers MA, Oliphant M, Berne AS, Feldberg MA. The peritoneal ligaments and mesenteries: pathways of intraabdominal spread of disease. Radiology. 1987;163:593–604.
    1. Rubenstein WA, Auh YH, Whalen JP, Kazam E. The perihepatic spaces: computed tomographic and ultrasound imaging. Radiology. 1983;149:231–9.
    1. Dodds WJ, Foley WD, Lawson TL, Stewart ET, Taylor A. Anatomy and imaging of the lesser peritoneal sac. AJR Am J Roentgenol. 1985;144:567–75.
    1. Kneeland JB, Auh YH, Rubenstein WA, et al. Perirenal spaces: CT evidence for communication across the midline. Radiology. 1987;164:657–64.
    1. Meyers MA. Roentgen significance of the phrenicocolic ligament. Radiology. 1970;95:539–45.
    1. Hewitt MJ, Hall GD, Wilkinson N, Perren TJ, Lane G, Spencer JA. Image-guided biopsy in women with breast cancer presenting with peritoneal carcinomatosis. Int J Gynecol Cancer. 2006;16(Suppl 1):108–10. doi: 10.1111/j.1525-1438.2006.00322.x.
    1. Hewitt MJ, Anderson K, Hall GD, et al. Women with peritoneal carcinomatosis of unknown origin: efficacy of image-guided biopsy to determine site-specific diagnosis. BJOG. 2007;114:46–50.
    1. Pannu HK, Bristow RE, Montz FJ, Fishman EK. Multidetector CT of peritoneal carcinomatosis from ovarian cancer. Radiographics. 2003;23:687–701. doi: 10.1148/rg.233025105.
    1. Pannu HK, Horton KM, Fishman EK. Thin section dual-phase multidetector-row computed tomography detection of peritoneal metastases in gynecologic cancers. J Comput Assist Tomogr. 2003;27:333–40. doi: 10.1097/00004728-200305000-00006.
    1. Coakley FV, Choi PH, Gougoutas CA, et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology. 2002;223:495–9. doi: 10.1148/radiol.2232011081.
    1. Franiel T, Diederichs G, Engelken F, Elgeti T, Rost J, Rogalla P. Multi-detector CT in peritoneal carcinomatosis: diagnostic role of thin slices and multiplanar reconstructions. Abdom Imaging. 2009;34:49–54. doi: 10.1007/s00261-008-9372-z.
    1. Marin D, Catalano C, Baski M, et al. 64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings. Abdom Imaging. 2010;35:694–70. doi: 10.1007/s00261-008-9464-9.
    1. deBree BE, Koops W, Kroger R, vanRuth S, Witkamp AJ, Zoetmulder FA. Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol. 2004;86:64–73. doi: 10.1002/jso.20049.
    1. Low RN. MR imaging of the peritoneal spread of malignancy. Abdom Imaging. 2007;32:267–83. doi: 10.1007/s00261-007-9210-8.
    1. Low RN, Barone RM, Lacey C, Sigeti JS, Alzate GD, Sebrechts CP. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology. 1997;204:513–20.
    1. Low RN. Diffusion-weighted MR imaging for whole body metastatic disease and lymphadenopathy. Magn Reson Imaging Clin N Am. 2009;17:245–61. doi: 10.1016/j.mric.2009.01.006.
    1. Low RN, Sigeti JS. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging. AJR Am J Roentgenol. 1994;163:1131–40.
    1. Kyriazi S, Kaye SB, Desouza NM. Imaging ovarian cancer and peritoneal metastases – current and emerging techniques. Nat Rev Clin Oncol. 2010;7:381–9. doi: 10.1038/nrclinonc.2010.47.
    1. Turlakow A, Yeung HW, Salmon AS, Macapinlac HA, Larson SM. Peritoneal carcinomatosis: role of (18)F-FDG PET. J Nucl Med. 2003;44:1407–12.
    1. Yoshida Y, Kurokawa T, Kawahara K, et al. Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer. AJR Am J Roentgenol. 2004;182:227–33.
    1. Kitajima K, Murakami K, Yamasaki E, et al. Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT. Eur J Nucl Med Mol Imaging. 2008;35:1912–20. doi: 10.1007/s00259-008-0890-2.
    1. Kitajima K, Murakami K, Yamasaki E, et al. Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT. Eur J Nucl Med Mol Imaging. 2008;35:1439–48. doi: 10.1007/s00259-008-0776-3.
    1. Dirisamer A, Schima W, Heinisch M, et al. Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT. Eur J Radiol. 2009;69:536–41. doi: 10.1016/j.ejrad.2007.11.032.
    1. Pannu HK, Cohade C, Bristow RE, Fishman EK, Wahl RL. PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation. Abdom Imaging. 2004;29:398–403.
    1. Gu P, Pan LL, Wu SQ, Sun L, Huang G. CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis. Eur J Radiol. 2009;71:164–74. doi: 10.1016/j.ejrad.2008.02.019.
    1. Pannu HK, Bristow RE, Cohade C, Fishman EK, Wahl RL. PET-CT in recurrent ovarian cancer: initial observations. Radiographics. 2004;24:209–23. doi: 10.1148/rg.241035078.
    1. Blake MA, Singh A, Setty BN, et al. Pearls and pitfalls in interpretation of abdominal and pelvic PET-CT. Radiographics. 2006;26:1335–53. doi: 10.1148/rg.265055208.
    1. Anthony MP, Khong PL, Zhang J. Spectrum of (18)F-FDG PET/CT appearances in peritoneal disease. AJR Am J Roentgenol. 2009;193:W523–9. doi: 10.2214/AJR.09.2936.
    1. Fujii S, Matsusue E, Kanasaki Y, et al. Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol. 2008;18:18–23. doi: 10.1007/s00330-007-0732-9.
    1. Sala E, Priest AN, Kataoka M, et al. Apparent diffusion coefficient and vascular signal fraction measurements with magnetic resonance imaging: feasibility in metastatic ovarian cancer at 3 Tesla: technical development. Eur Radiol. 2010;20:491–6. doi: 10.1007/s00330-009-1543-y.
    1. Low RN, Sebrechts CP, Barone RM, Muller W. Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings–a feasibility study. AJR Am J Roentgenol. 2009;193:461–70. doi: 10.2214/AJR.08.1753.
    1. Priest AN, Gill AB, Kataoka M, et al. Dynamic contrast-enhanced MRI in ovarian cancer: initial experience at 3 tesla in primary and metastatic disease. Magn Reson Med. 2010;63:1044–9. doi: 10.1002/mrm.22291.
    1. McLean MA, Priest AN, Joubert I, et al. Metabolic characterization of primary and metastatic ovarian cancer by 1H-MRS in vivo at 3T. Magn Reson Med. 2009;62:855–61. doi: 10.1002/mrm.22067.
    1. Yoshida Y, Kurokawa T, Sawamura Y, et al. The positron emission tomography with F18 17beta-estradiol has the potential to benefit diagnosis and treatment of endometrial cancer. Gynecol Oncol. 2007;104:764–6. doi: 10.1016/j.ygyno.2006.10.024.
    1. Yoshida Y, Kurokawa T, Tsujikawa T, Okazawa H, Kotsuji F. Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16alpha-18F-fluoro-17beta-estradiol PET. J Ovarian Res. 2009;2:7. doi: 10.1186/1757-2215-2-7.
    1. Woodward PJ, Hosseinzadeh K, Saenger JS. From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation. Radiographics. 2004;24:225–46. doi: 10.1148/rg.241035178.
    1. Matsuoka Y, Itai Y, Ohtomo K, Nishikawa J, Sasaki Y. Calcification of peritoneal carcinomatosis from gastric carcinoma: a CT demonstration. Eur J Radiol. 1991;13:207–8. doi: 10.1016/0720-048X(91)90031-P.
    1. Matsuoka Y, Ohtomo K, Itai Y, Nishikawa J, Yoshikawa K, Sasaki Y. Pseudomyxoma peritonei with progressive calcifications: CT findings. Gastrointest Radiol. 1992;17:16–18. doi: 10.1007/BF01888499.
    1. Mitchell DG, Hill MC, Hill S, Zaloudek C. Serous carcinoma of the ovary: CT identification of metastatic calcified implants. Radiology. 1986;158:649–52.
    1. Amin Z, Reznek RH. Peritoneal metastases. In: Husband JE, Reznek RH, editors. Imaging in oncology. 3rd. Informa Healthcare; 2009. pp. 1094–114.
    1. Kawamoto S, Urban BA, Fishman EK. CT of epithelial ovarian tumors. Radiographics. 1999;19:S85–102.
    1. Mueller PR, Ferrucci JT, Jr, Harbin WP, Kirkpatrick RH, Simeone JF, Wittenberg J. Appearance of lymphomatous involvement of the mesentery by ultrasonography and body computed tomography: the "sandwich sign". Radiology. 1980;134:467–73.
    1. Walkey MM, Friedman AC, Sohotra P, Radecki PD. CT manifestations of peritoneal carcinomatosis. AJR Am J Roentgenol. 1988;150:1035–41.
    1. Coakley FV, Choi PH, Gougoutas CA, et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology. 2002;223:495–9. doi: 10.1148/radiol.2232011081.
    1. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to “pseudomyxoma peritonei”. Am J Surg Pathol. 1995;19:1390–408. doi: 10.1097/00000478-199512000-00006.
    1. Ronnett BM, Kurman RJ, Zahn CM, et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol. 1995;26:509–24. doi: 10.1016/0046-8177(95)90247-3.
    1. Diamond RT, Greenberg HM, Boult IF. Direct metastatic spread of right colonic adenocarcinoma to duodenum–barium and computed tomographic findings. Gastrointest Radiol. 1981;6:339–41. doi: 10.1007/BF01890282.
    1. Meyers MA. Treitz redux: the ligament of Treitz revisited. Abdom Imaging. 1995;20:421–4. doi: 10.1007/BF01213262.
    1. Ha HK, Baek SY, Kim SH, Kim HH, Chung EC, Yeon KM. Krukenberg's tumor of the ovary: MR imaging features. AJR Am J Roentgenol. 1995;164:1435–9.
    1. Whitley NO, Brenner DE, Antman KH, Grant D, Aisner J. CT of peritoneal mesothelioma: analysis of eight cases. AJR Am J Roentgenol. 1982;138:531–5.
    1. Guest PJ, Reznek RH, Selleslag D, Geraghty R, Slevin M. Peritoneal mesothelioma: the role of computed tomography in diagnosis and follow up. Clin Radiol. 1992;45:79–84. doi: 10.1016/S0009-9260(05)80059-5.
    1. Smith TR. Malignant peritoneal mesothelioma: marked variability of CT findings. Abdom Imaging. 1994;19:27–9. doi: 10.1007/BF02165856.
    1. vanRuth S, Bronkhorst MW, vanCoevorden F, Zoetmulder FA. Peritoneal benign cystic mesothelioma: a case report and review of the literature. Eur J Surg Oncol. 2002;28:192–5. doi: 10.1053/ejso.2000.1215.
    1. Levy AD, Arnaiz J, Shaw JC, Sobin LH. From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation. Radiographics. 2008;28:583–607. doi: 10.1148/rg.282075175.
    1. Mok SC, Schorge JO, Welch WR, Hendricksen MR, Kempson RL. Peritoneal tumours. In: Tavassoli FA, Devilee P, editors. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC; 2003. pp. 197–202.
    1. Chiou SY, Sheu MH, Wang JH, Chang CY. Peritoneal serous papillary carcinoma: a reappraisal of CT imaging features and literature review. Abdom Imaging. 2003;28:815–19.
    1. Hiralal, Gamanagatti S, Thulkar S, Rao SK. Desmoplastic round cell tumour of the abdomen. Singapore Med J. 2007;48:e19–21.
    1. Pickhardt PJ, Fisher AJ, Balfe DM, Dehner LP, Huettner PC. Desmoplastic small round cell tumor of the abdomen: radiologic-histopathologic correlation. Radiology. 1999;210:633–8.
    1. Levy AD, Shaw JC, Sobin LH. Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation. Radiographics. 2009;29:347–73. doi: 10.1148/rg.292085189.
    1. Paes FM, Kalkanis DG, Sideras PA, Serafini AN. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics. 2010;30:269–91. doi: 10.1148/rg.301095088.
    1. Papadatos D, Taourel P, Bret PM. CT of leiomyomatosis peritonealis disseminata mimicking peritoneal carcinomatosis. AJR Am J Roentgenol. 1996;167:475–6.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren